Results are in for a new depression drug trial, and they're cratering this stock
Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, fell short of expectations in a late-stage clinical trial, disappointing Wall Street.
Neumora shares slump after depression drug fails in key trial
Jan 2 (Reuters) - Neumora Therapeutics' (NMRA.O), opens new tab shares tumbled more than 80% on Thursday after its experimental depression drug failed to reduce symptoms such as sadness and pessimistic thoughts in a key study, raising concerns over the ...
Neumora’s Novel Depression Drug Strikes Out in First Pivotal Trial
In a highly anticipated readout for the kappa opioid receptor class in major depressive disorder, Neumora’s navacaprant failed to meet the primary and key secondary endpoint in the first of three identical Phase III studies.
Neumora Therapeutics’ stock craters after trial of major depressive disorder fails to meet main goals
Neumora Therapeutics Inc.’s stock tumbled 80% Thursday, after the clinical-stage biotech said a late-stage trial of a treatment for major depressive disorder failed to meet its main goals. The Watertown,
Neumora's depression drug fails trial, sinking shares
CNBC’s Angelica Peebles joins 'Power Lunch' to discuss Neumora's depression drug failing its trial results. What is Turo, the app involved in Cybertruck blast and New Orleans attack? Patriots pull off massive trade with No.
Neumora Therapeutics Stock Tanks as Its Depression Drug Misses Goals
Key Takeaways Neumora Therapeutics reported its experimental depression drug didn't meet expectations, and shares plunged.The biopharmaceutical firm's navacaprant treatment failed to reach both primary and secondary endpoints.
Neumora Therapeutics Stock Crashes 81% After Depression Drug Flops
Neumora Therapeutics stock collapsed Thursday after its experimental depression treatment failed in the first of three studies.
Stock in Biotech Neumora Plunges 80% as Depression Drug Fails
Patients who received the drug, called navacaprant, showed no more improvement in depressive symptoms than people who received a placebo.
CounterPunch3d
Psychiatry’s Latest Insane Magic-Bullet Treatment for Depression: Why Ketamine?
Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...
Neumora Plunges After Major Depression Drug Fails in Study
Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...
Rolling Out2d
Can depression be treated with magic mushroom or are you just high?
Studies show psilocybin from mushrooms could revolutionize depression treatment offering hope to millions who don't respond to traditional medications.
Nerve-stimulation therapy can get people out of severe depression
Participants in clinic trial went from being unable to get out of bed to being productive and interacting with loved ones ...
Depression Breakthrough: UCSF Scientists Discover How to Make Stressed Brains Happy Again
Scientists have discovered how brain circuits affected by stress can predict resilience in mice. By stimulating certain ...
STAT3d
Merck is a new year outlier with its diabetes drug
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Happy New Year, biotech ...